Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Antonio, Texas 78284


OBJECTIVES: I. Determine whether the benzodiazepine alprazolam reinforces self-medication behavior in anxious patients with varying histories of using other drugs. II. Establish outpatient methods for the study of self-medication and drug reinforcement in patients vulnerable to prescription drug abuse or dependence. III. Evaluate the influence of alcohol and other non-prescription drug use as determinants of vulnerability in these patients. IV. Identify personality, attitudinal, or other variables that might predict different patterns of self-medication. V. Assess the effects of cognitive-behavioral therapy on alprazolam self-medication.

Study summary:

PROTOCOL OUTLINE: This protocol involves different experiments examining self-medication with anxiolytic medications in selected patients, and cognitive-behavioral therapy for anxiety. Capsules are color coded and taken under double-blind conditions. Compliance is monitored with the Medication Event Monitoring System, which automatically registers the date and time each bottle is opened. The physician directs therapy administration, using some combination of the following: blind choice test, antianxiety agent(s), placebo, and cognitive-behavioral therapy.


PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- - Primary diagnosis of generalized anxiety or panic disorder Determined by Structured Clinical Interview for DSM IV - Hamilton Anxiety Scale (HAM-A) score at least 14 AND Profile of Mood States (POMS) tension/anxiety scale score at least 20 - Concurrent diagnoses allowed: Mild to moderate agoraphobia Simple or social phobias Secondary unipolar affective disorders - No current substance abuse, dependence, or substance abuse treatment Drug-free urine sample required - No history of other primary Axis I diagnosis other than tobacco dependence --Prior/Concurrent Therapy-- - No prior formalized non-drug therapy for anxiety disorder - No concurrent prescription psychoactive medication - No history of benzodiazepine dependence --Patient Characteristics-- - Age: 18 to 50 - Other: Medically healthy Negative pregnancy test required No occupational requirement to work in hazardous situations



Primary Contact:

Study Chair
John D. Roache
University of Texas

Backup Contact:


Location Contact:

San Antonio, Texas 78284
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.